UK markets closed

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
42.03+0.13 (+0.31%)
At close: 04:00PM EST
42.17 +0.14 (+0.34%)
After hours: 07:58PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 85.14B
Enterprise value 101.58B
Trailing P/E 13.85
Forward P/E 10.62
PEG ratio (5-yr expected) 1.31
Price/sales (ttm)2.25
Price/book (mrq)5.05
Enterprise value/revenue 3.35
Enterprise value/EBITDA 10.47

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 322.00%
S&P500 52-week change 326.89%
52-week high 342.69
52-week low 333.20
50-day moving average 339.97
200-day moving average 336.60

Share statistics

Avg vol (3-month) 33.63M
Avg vol (10-day) 33.87M
Shares outstanding 52.03B
Implied shares outstanding 62.11B
Float 83.91B
% held by insiders 10.05%
% held by institutions 114.55%
Shares short (15 Feb 2024) 43.29M
Short ratio (15 Feb 2024) 41.02
Short % of float (15 Feb 2024) 4N/A
Short % of shares outstanding (15 Feb 2024) 40.23%
Shares short (prior month 12 Jan 2024) 42.78M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 43.49%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 31.38%
5-year average dividend yield 45.00
Payout ratio 446.93%
Dividend date 311 Apr 2024
Ex-dividend date 422 Feb 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 16.25%
Operating margin (ttm)14.13%

Management effectiveness

Return on assets (ttm)8.30%
Return on equity (ttm)46.38%

Income statement

Revenue (ttm)30.33B
Revenue per share (ttm)14.97
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
Net income avi to common (ttm)4.93B
Diluted EPS (ttm)3.03
Quarterly earnings growth (yoy)-82.50%

Balance sheet

Total cash (mrq)5.18B
Total cash per share (mrq)1.28
Total debt (mrq)18.02B
Total debt/equity (mrq)140.82%
Current ratio (mrq)0.88
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)6.77B
Levered free cash flow (ttm)2.55B